An international research team is the first to use artificial intelligence (AI) analysis to identify dual-purpose target candidates for the treatment of cancer and ageing. Researchers from the University of…
…machine learning and artificial intelligence to enable the acceleration of oncology drug development. Dr Kittaneh has more than 15 years’ medical practice experience and was an Associate Professor of Medicine…
…Harvard Medical School (HMS) in the US and the University of Oxford have developed a new artificial intelligence (AI) tool named EVEscape that can predict new viral variants before they…
…2023. “Using artificial intelligence, AU-007 is designed to bind to IL-2 precisely instead of the IL-2 receptor. The result is a novel mechanism of action showing early promise in overcoming…
…considerably lower doses of radiation, meaning more patients, including children, can participate in clinical trials. NPIP’s network of infrastructure and intelligence will also connect insights from many research programmes and…
Seven companies have been highlighted in Clarivate’s ‘Companies to Watch Report’ for delivering more effective and safer medicines to market faster by leveraging artificial intelligence (AI) and machine learning (ML)…
…study, the researchers combined Insilico’s artificial intelligence (AI)-driven target identification engine PandaOmics with the FuzDrop method for predicting protein separation to identify PPS-prone disease-associated proteins. Recent research has demonstrated that…
ICON, a healthcare intelligence and clinical research organisation, with the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the US…
News round-up for 11-15 September by DDW Digital Content Editor Diana Spencer. Spanning artificial intelligence, theranostics, radiopharmaceuticals, quantum simulation and small regulatory RNA, the top stories this week all cover…
Cambridge data analytics company Qureight has announced a multi-year strategic research collaboration with AstraZeneca. The agreement will allow AstraZeneca to use Qureight’s proprietary platform and artificial intelligence (AI) technology to…
Researchers will combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future. Under…
Three drugs that could help stave off the effects of ageing have been discovered using artificial intelligence (AI), a study by Edinburgh researchers suggests. Findings suggest the drugs can safely…
…the researchers will prioritise the top drug candidates, using both laboratory-based tests on motor neurons grown in the lab from patient donated stem cells, and a machine-learning, artificial intelligence approach…
…original approach or new, advanced technology. Whether it be a monoclonal antibody to treat peanut allergy, or using artificial intelligence (AI) to identify influenza drug targets, each discovery reflects the…
…problem, either through the use of an original approach or new, advanced technology. Whether it be a monoclonal antibody to treat peanut allergy, or using artificial intelligence (AI) to identify…
